Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1957 Sep 21;2(5046):661–665. doi: 10.1136/bmj.2.5046.661

The Lupus Erythematosus Cell and its Significance*

M Wilkinson, L S Sacker
PMCID: PMC1962279  PMID: 13460347

Full text

PDF
661

Images in this article

663Fig. 2
on p.663

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARNES S. S., MOFFATT T. W., LANE C. W., WEISS R. S. Studies on the L. E. phenomenon. AMA Arch Derm Syphilol. 1950 Dec;62(6):771–785. doi: 10.1001/archderm.1950.01530190003001. [DOI] [PubMed] [Google Scholar]
  2. BERMAN L., AXELROD A. R., GOODMAN H. L., McCLAUGHRY R. I. So-called "lupus erythematosus inclusion phenomenon" of bone marrow and blood. Am J Clin Pathol. 1950 May;20(5):403–418. doi: 10.1093/ajcp/20.5.403. [DOI] [PubMed] [Google Scholar]
  3. BRIDGE R. G., FOLEY F. E. Placental transmission of the lupus erythematosus factor. Am J Med Sci. 1954 Jan;227(1):1–8. doi: 10.1097/00000441-195401000-00001. [DOI] [PubMed] [Google Scholar]
  4. COMENS P. Experimental hydralazine disease and its similarity to disseminated lupus erythematosus. J Lab Clin Med. 1956 Mar;47(3):444–454. [PubMed] [Google Scholar]
  5. DUBOIS E. L. Acquired hemolytic anemias the presenting syndrome of lupus erythematosus disseminatus. Am J Med. 1952 Feb;12(2):197–204. doi: 10.1016/0002-9343(52)90212-x. [DOI] [PubMed] [Google Scholar]
  6. DUBOIS E. L. Simplified method for the L. E. cell test; results of a three-year study of seven hundred tests in many disease states. AMA Arch Intern Med. 1953 Aug;92(2):168–184. doi: 10.1001/archinte.1953.00240200018003. [DOI] [PubMed] [Google Scholar]
  7. FALLET G. H., SPAHR J., MEGEVAND A., ROTH G., CASTELLA H., GOLDSCHLAG H. Le lupus érythémateux disséminé; (lupo-érythémato-viscérite maligne) et son diagnostic hématologique; étude de six observations. Sem Hop. 1955 Nov 30;31(70/7):3737–3749. [PubMed] [Google Scholar]
  8. GOLD S. C., GOWING N. F. Systemic lupus erythematosus; a clinical and pathological study. Q J Med. 1953 Oct;22(88):457–481. [PubMed] [Google Scholar]
  9. GUEFT B. Depolymerization of nucleic acid in acute disseminated lupus erythematosus. Arch Derm Syphilol. 1950 Jun;61(6):892–897. doi: 10.1001/archderm.1950.01530130010003. [DOI] [PubMed] [Google Scholar]
  10. HARGRAVES M. M. The L.E. cell phenomenon. Adv Intern Med. 1954;6:133–160. [PubMed] [Google Scholar]
  11. HARVEY A. M., SHULMAN L. E., TUMULTY P. A., CONLEY C. L., SCHOENRICH E. H. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954 Dec;33(4):291–437. [PubMed] [Google Scholar]
  12. HASERICK J. R. Blood factor in acute disseminated lupus erythematosus. Arch Derm Syphilol. 1950 Jun;61(6):889–891. doi: 10.1001/archderm.1950.01530130007002. [DOI] [PubMed] [Google Scholar]
  13. HASERICK J. R., LEWIS L. A. Blood factor in acute disseminated lupus erythematosus; induction of specific antibodies against L. E. factor. Blood. 1950 Aug;5(8):718–722. [PubMed] [Google Scholar]
  14. HELLER P., ZIMMERMAN H. J. Nucleophagocytosis; studies on three hundred thirty-six patients. AMA Arch Intern Med. 1956 Apr;97(4):403–408. doi: 10.1001/archinte.1956.00250220023002. [DOI] [PubMed] [Google Scholar]
  15. JACOBS A. G. A false-positive lupus erythematosus test. Ann Intern Med. 1955 May;42(5):1097–1100. doi: 10.7326/0003-4819-42-5-1097. [DOI] [PubMed] [Google Scholar]
  16. JOSKE R. A., KING W. E. The L.E.-cell phenomenon in active chronic viral hepatitis. Lancet. 1955 Sep 3;269(6888):477–480. doi: 10.1016/s0140-6736(55)93331-6. [DOI] [PubMed] [Google Scholar]
  17. KOFMAN S., JOHNSON G. C., ZIMMERMAN H. J. Apparent hepatic dysfunction in lupus erythematosus. AMA Arch Intern Med. 1955 May;95(5):669–676. doi: 10.1001/archinte.1955.00250110039005. [DOI] [PubMed] [Google Scholar]
  18. KURNICK N. B., SCHWARTZ L. I., PARISER S., LEE S. L. A specific inhibitor for human desoxyribonuclease and an inhibitor of the lupus erythematosus cell phenomenon from leucocytes. J Clin Invest. 1953 Mar;32(3):193–201. doi: 10.1172/JCI102727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. LEE S. L. A simple test for L. E. cells. Am J Clin Pathol. 1951 May;21(5):492–496. doi: 10.1093/ajcp/21.5_ts.492. [DOI] [PubMed] [Google Scholar]
  20. LEE S. L., MICHAEL S. R., VURAL I. L. The L.E. (lupus erythematosus) cell; clinical and chemical studies. Am J Med. 1951 Apr;10(4):446–451. doi: 10.1016/0002-9343(51)90289-6. [DOI] [PubMed] [Google Scholar]
  21. LINCOLN M., RICKER W. A. A case of periarteritis nodosa with L.E. cells; apparent complete remission with cortisone therapy. Ann Intern Med. 1954 Sep;41(3):639–646. doi: 10.7326/0003-4819-41-3-639. [DOI] [PubMed] [Google Scholar]
  22. MACLEAN K., ROBINSON H. S. Sjogren's syndrome. Can Med Assoc J. 1954 Dec;71(6):597–599. [PMC free article] [PubMed] [Google Scholar]
  23. MARMONT A. Value and limitations of the L.E. cell test in the syndrome known as systemic lupus erythematosus without skin eruptions. Acta Haematol. 1955 May;13(5):257–272. doi: 10.1159/000204946. [DOI] [PubMed] [Google Scholar]
  24. MARTEN R. H., BLACKBURN E. K. A simple method for the detection of L.E. cells. J Clin Pathol. 1953 Feb;6(1):89–90. doi: 10.1136/jcp.6.1.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. MATHIS H. B. A simple office procedure for demonstrating lupus erythematosus cells in peripheral blood. Blood. 1951 May;6(5):470–473. [PubMed] [Google Scholar]
  26. MEYLER L. Phagocystosis in drug allergy. Acta Med Scand. 1954;150(1):33–38. [PubMed] [Google Scholar]
  27. MacDONALD G. R., SIMMONS N. W. Lupus erythematosus; the effect of cortisone on the "L. E." phenomenon in lupus erythematosus. Can Med Assoc J. 1950 Nov;63(5):477–478. [PMC free article] [PubMed] [Google Scholar]
  28. PARELHOFF M. E. Demonstration of the L. E. cell phenomenon in subacute glomerulonephritis. Sinai Hosp J (Balt) 1953 Nov;2(2):12–20. [PubMed] [Google Scholar]
  29. PISCIOTTA A. V., GILIBERTI J. J., GREENWALT T. J., ENGSTROM W. W. Acute hemolytic anemia in disseminated lupus erythematosus; treatment with cortisone; report of case. Am J Clin Pathol. 1951 Dec;21(12):1139–1144. doi: 10.1093/ajcp/21.12.1139. [DOI] [PubMed] [Google Scholar]
  30. RASPONI L. Osservazioni sul fenomeno L. E. I. Il fenomeno L. E. nelle varietà cliniche dell'erythematodes. Arch Ital Dermatol Sifilogr Venereol. 1954;26(2):121–140. [PubMed] [Google Scholar]
  31. ROHN R. J., BOND W. H. Some supravital observations on the L.E. phenomenon. Am J Med. 1952 Apr;12(4):422–432. doi: 10.1016/0002-9343(52)90223-4. [DOI] [PubMed] [Google Scholar]
  32. SHEARN M. A., PIROFSKY B. Disseminated lupus erythematosus; analysis of thirty-four cases. AMA Arch Intern Med. 1952 Dec;90(6):790–807. doi: 10.1001/archinte.1952.00240120065007. [DOI] [PubMed] [Google Scholar]
  33. SICKLEY J. F., FRIEDMAN I. A., FELDHAKE C., SCHWARTZ S. O. In vivo demonstration of the lupus erythematosus phenomenon. J Lab Clin Med. 1955 Oct;46(4):624–627. [PubMed] [Google Scholar]
  34. SLOCUMB C. H. Rheumatic complaints during chronic hypercortisonism and syndromes during withdrawal of cortisone in rheumatic patients. Proc Staff Meet Mayo Clin. 1953 Nov 18;28(23):655–657. [PubMed] [Google Scholar]
  35. SNAPPER I., NATHAN D. J. The mechanics of the L.E. cell phenomenon, studied with a simplified test. Blood. 1955 Jul;10(7):718–729. [PubMed] [Google Scholar]
  36. SOFFER L. J., ELSTER S. K., HAMERMAN D. J. Treatment of acute disseminated lupus erythematosus with corticotropin and cortisone. AMA Arch Intern Med. 1954 Apr;93(4):503–514. doi: 10.1001/archinte.1954.00240280023003. [DOI] [PubMed] [Google Scholar]
  37. TRUBOWITZ S. The sternal marrow aspiration of amyloid in multiple myeloma. Blood. 1950 Jun;5(6):581–585. [PubMed] [Google Scholar]
  38. VOLPE R., HAUCH J. T. A case of scleroderma with L.E. cells and prolonged remission on cortisone therapy. Can Med Assoc J. 1955 Apr 15;72(8):597–599. [PMC free article] [PubMed] [Google Scholar]
  39. WALSH J. R., EGAN R. L. The reliability of the L. E. test. N Engl J Med. 1952 May 15;246(20):775–776. doi: 10.1056/NEJM195205152462004. [DOI] [PubMed] [Google Scholar]
  40. WATSON J. B., O'LEARY P. A., HARGRAVES M. M. Neutrophils resembling L. E. cells in artificial blisters. AMA Arch Derm Syphilol. 1951 Mar;63(3):328–333. doi: 10.1001/archderm.1951.01570030042004. [DOI] [PubMed] [Google Scholar]
  41. WEISBERGER A. S., MEACHAM G. C., HEINLE R. W. Simple method for demonstrating the L E phenomenon in peripheral blood. J Lab Clin Med. 1952 Mar;39(3):480–483. [PubMed] [Google Scholar]
  42. WEISS R. S., SWIFT S. The significance of a positive L. E. phenomenon. AMA Arch Derm. 1955 Aug;72(2):103–112. doi: 10.1001/archderm.1955.03730320001001. [DOI] [PubMed] [Google Scholar]
  43. ZIMMER F. E., HARGRAVES M. M. The effect of blood coagulation on L.E. cell formation. Proc Staff Meet Mayo Clin. 1952 Oct 22;27(22):424–430. [PubMed] [Google Scholar]
  44. ZIMMERMAN H. J., WALSH J. R., HELLER P. Production of nucleophagocytosis by rabbit antileukocytic serum. Blood. 1953 Jul;8(7):651–654. [PubMed] [Google Scholar]
  45. ZINKHAM W. H., CONLEY C. L. Some factors influencing the formation of L.E. cells; a method for enhancing L.E. cell production. Bull Johns Hopkins Hosp. 1956 Feb;98(2):102–119. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES